Literature DB >> 28738937

Percutaneous Tracheostomy under Bronchoscopic Visualization Does Not Affect Short-Term or Long-Term Complications.

Thomas S Easterday, Joshua W Moore, Meredith H Redden, David V Feliciano, Vernon J Henderson, Timothy Humphries, Katherine E Kohler, Philip T Ramsay, Stanston D Spence, Mark Walker, Amy D Wyrzykowski.   

Abstract

Percutaneous tracheostomy is a safe and effective bedside procedure. Some advocate the use of bronchoscopy during the procedure to reduce the rate of complications. We evaluated our complication rate in trauma patients undergoing percutaneous tracheostomy with and without bronchoscopic guidance to ascertain if there was a difference in the rate of complications. A retrospective review of all tracheostomies performed in critically ill trauma patients was performed using the trauma registry from an urban, Level I Trauma Center. Bronchoscopy assistance was used based on surgeon preference. Standard statistical methodology was used to determine if there was a difference in complication rates for procedures performed with and without the bronchoscope. From January 2007, to April 2016, 649 patients underwent modified percuteaneous tracheostomy; 289 with the aid of a bronchoscope and 360 without. There were no statistically significant differences in any type of complication regardless of utilization of a bronchoscope. The addition of bronchoscopy provides several theoretical benefits when performing percutaneous tracheostomy. Our findings, however, do not demonstrate a statistically significant difference in complications between procedures performed with and without a bronchoscope. Use of the bronchoscope should, therefore, be left to the discretion of the performing physician.

Entities:  

Mesh:

Year:  2017        PMID: 28738937

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  1 in total

1.  The role of routine FIBERoptic bronchoscopy monitoring during percutaneous dilatational TRACHeostomy (FIBERTRACH): a study protocol for a randomized, controlled clinical trial.

Authors:  José M Añón; María Soledad Arellano; Manuel Pérez-Márquez; Claudia Díaz-Alvariño; José A Márquez-Alonso; Jorge Rodríguez-Peláez; Kapil Nanwani-Nanwani; Ana Martín-Pellicer; Belén Civantos; Alba López-Fernández; Irene Seises; Jorge García-Nerín; Juan C Figueira; Henar Casero; Javier Vejo; Alexander Agrifoglio; Lucía Cachafeiro; Mariana Díaz-Almirón; Jesús Villar
Journal:  Trials       Date:  2021-06-29       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.